N-(7-(5-Amino-2-methylphenyl)isoquinolin-3-yl)cyclopropanecarboxamide

Catalog No. :
ACISBX147
CAS No. :
1382851-04-8
Molecular Formula :
C20H19N3O
Molecular Weight :
317.39

IUPAC Name:N-(7-(5-amino-2-methylphenyl)isoquinolin-3-yl)cyclopropanecarboxamide

N-(7-(5-Amino-2-methylphenyl)isoquinolin-3-yl)cyclopropanecarboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$159.00Login to see priceInquiryInquiry
1g97%$398.00Login to see priceInquiryInquiry
5g97%$1194.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(7-(5-Amino-2-methylphenyl)isoquinolin-3-yl)cyclopropanecarboxamide
IUPAC NameN-(7-(5-amino-2-methylphenyl)isoquinolin-3-yl)cyclopropanecarboxamide
MDL No.MFCD29921600
Molecular FormulaC20H19N3O
Molecular Weight317.39
SMILESO=C(C1CC1)NC2=CC3=C(C=N2)C=C(C4=CC(N)=CC=C4C)C=C3
InChI KeyLTOXEIVACTZWFQ-UHFFFAOYSA-N
SynonymN-(7-(5-AMINO-2-METHYLPHENYL)ISOQUINOLIN-3-YL)CYCLOPROPANECARBOXAMIDE;Cyclopropanecarboxamide, N-[7-(5-amino-2-methylphenyl)-3-isoquinolinyl]-
CAS No.1382851-04-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACISBX147 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRAWC965 route compound structure diagram
    ACRAWC965882670-69-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACISBX147 route product structure diagram
    ACISBX1471382851-04-8
Inquiry

2. ACISBX147 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACISBX147 route product structure diagram
    ACISBX1471382851-04-8
Inquiry

Comments (0)